Natera, Inc.
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Panorama Non-Invasive Prenatal Test Revenue [legacy by Quarter
Panorama Non-Invasive Prenatal Test (NIPT) Revenue ($M) [legacy through Q3 2019] ($M)
Natera Panorama Non-Invasive Prenatal Test Revenue [legacy: $37.6M in Q3 2019, up 4.3% from a year earlier. That is the highest of the 10 quarters on record here. No newer figure appears in the documents we track.
Where the Q3 2019 figure comes from
Source: Form 10-Q (2019-11-08) ↗
Reported in Form 10-K/10-Q Note — Disaggregated Product Revenue (2016–2019Q3).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Panorama Non-Invasive Prenatal Test (NIPT) Revenue ($M) [legacy through Q3 2019] ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2019 | Sep 30, 2019 | 37.6 | +4.3% | Form 10-Q (2019-11-08) ↗ |
| Q2 2019 | Jun 30, 2019 | 36.5 | +2.1% | Form 10-Q (2019-08-09) ↗ |
| Q1 2019 | Mar 31, 2019 | 37.3 | +12.0% | Form 10-Q (2019-05-10) ↗ |
| Q4 2018 | Dec 31, 2018 | 36.0 | +16.2% | Form 10-K (2019-03-15) ↗ |
| Q3 2018 | Sep 30, 2018 | 36 | +6.2% | Form 10-Q (2019-11-08) ↗ |
| Q2 2018 | Jun 30, 2018 | 35.7 | +13.3% | Form 10-Q (2019-08-09) ↗ |
| Q1 2018 | Mar 31, 2018 | 33.3 | – | Form 10-Q (2019-05-10) ↗ |
| Q4 2017 | Dec 31, 2017 | 30.9 | – | Form 10-K (2019-03-15) ↗ |
| Q3 2017 | Sep 30, 2017 | 33.9 | – | Form 10-Q (2018-11-09) ↗ |
| Q2 2017 | Jun 30, 2017 | 31.5 | – | Form 10-Q (2018-08-09) ↗ |
Cite this data
StockData. (2026). Natera Panorama Non-Invasive Prenatal Test Revenue [legacy ($M), quarterly Q2 2017–Q3 2019 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/rev-legacy-panorama-nipt
See every metric in the Natera KPI table. Data updated Nov 2, 2026.